We are live on ! Find out more
CPHI icon

China Pharma Holdings

4 hedge funds and large institutions have $12.8K invested in China Pharma Holdings in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 44 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

0.01% less ownership

Funds ownership: 0.04%0.03% (-0.01%)

9% less capital invested

Capital invested by funds: $14K → $12.8K (-$1.2K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
4
Holders Change
Holders Change %
0%
% of All Funds
0.06%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
XT
1
XTX Topco
Cayman Islands
$5.1K -$1.58K -715 -25%
TSS
2
Two Sigma Securities
New York
$4.5K +$4.2K +1,905 New
MG
3
Marex Group
$3.17K +$2.96K +1,340 New
FCT
4
First Community Trust
Iowa
$7
BBA
5
Baader Bank Aktiengesellschaft
Germany
-$4.11K -2,031 Closed
Susquehanna International Group
6
Susquehanna International Group
Pennsylvania
-$2.71K -1,092 Closed

CPHI Hedge Fund Activity: Q3 2024 in Review

4 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q3 2024, worth a combined $12.8K — down 8.6% from $14K a quarter earlier.

Fund positioning in CPHI was balanced in Q3 2024: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 1 trimmed.

The largest buyer was Two Sigma Securities, opening a new position worth an estimated $4.2K. The largest seller was Baader Bank Aktiengesellschaft, exiting entirely with an estimated $4.11K sold.

  • 4 institutional investors held China Pharma Holdings (CPHI) as of Q3 2024, unchanged from Q2 2024.
  • Funds reported $12.8K of China Pharma Holdings stock for Q3 2024, down 8.6% quarter-over-quarter.
  • 2 funds opened new China Pharma Holdings positions in Q3 2024 and 2 closed out, a net change of 0 holders.
  • The largest China Pharma Holdings buyer in Q3 2024 was Two Sigma Securities, an estimated $4.2K added.
  • The largest China Pharma Holdings seller in Q3 2024 was Baader Bank Aktiengesellschaft, an estimated $4.11K sold.

Based on aggregated 13F filings for Q3 2024.